Go Pro
NASDAQ:MLAB

Mesa Laboratories (MLAB) Stock Price, News & Analysis

Mesa Laboratories logo
$109.62 -3.58 (-3.16%)
As of 12:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Mesa Laboratories Stock (NASDAQ:MLAB)

Advanced

Key Stats

Today's Range
$109.25
$115.43
50-Day Range
$91.36
$113.20
52-Week Range
$58.83
$115.52
Volume
67,207 shs
Average Volume
147,745 shs
Market Capitalization
$613.44 million
P/E Ratio
129.55
Dividend Yield
0.58%
Price Target
$110.00
Consensus Rating
Hold

Company Overview

Mesa Laboratories, Inc. (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications. Mesa Laboratories also offers calibration standards, software platforms and technical support services that enable clients to maintain accurate instrument performance and fulfill industry-specific quality assurance requirements.

Since its founding in 1968, Mesa Laboratories has expanded through a combination of in-house research and development and strategic acquisitions to broaden its instrumentation offerings and geographic reach. The company maintains manufacturing and service facilities across North America, Europe and the Asia-Pacific region, leveraging a global distribution network to deliver products and support to customers in more than 100 countries.

AI Generated. May Contain Errors.

Mesa Laboratories Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
20th Percentile Overall Score

MLAB MarketRank™: 

Mesa Laboratories scored higher than 20% of companies evaluated by MarketBeat, and ranked 826th out of 913 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Mesa Laboratories has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 3 hold ratings, and no sell ratings.

  • Downside Risk

    Mesa Laboratories has a consensus price target of $94.00, representing about 17.0% downside from its current price of $113.20.

  • Amount of Analyst Coverage

    Mesa Laboratories has only been the subject of 1 research reports in the past 90 days.

  • Read more about Mesa Laboratories' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Mesa Laboratories is 134.76, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.58.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Mesa Laboratories is 134.76, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 269.63.

  • Price to Book Value per Share Ratio

    Mesa Laboratories has a P/B Ratio of 3.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    5.96% of the float of Mesa Laboratories has been sold short.
  • Short Interest Ratio / Days to Cover

    Mesa Laboratories has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mesa Laboratories has recently increased by 18.21%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Mesa Laboratories has a dividend yield of 0.58%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Mesa Laboratories does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Mesa Laboratories is 76.19%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about Mesa Laboratories' dividend.
  • News Sentiment

    Mesa Laboratories has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for Mesa Laboratories this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for MLAB on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Mesa Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $770,122.00 in company stock.

  • Percentage Held by Insiders

    2.80% of the stock of Mesa Laboratories is held by insiders.

  • Percentage Held by Institutions

    90.60% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Mesa Laboratories' insider trading history.
Receive MLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MLAB Stock News Headlines

The world’s least risky AI stock?
Whitney Tilson, senior editor at Stansberry Research, has identified a company he calls the world's safest AI stock, one most investors have never heard of. The firm sits at the intersection of AI, energy, and defense, and one of America's most famous investors reportedly put roughly half his fund into it. In recent years it has returned more than Apple, Amazon, and the S&P 500 combined. Tilson has released a free presentation naming the company and its ticker symbol, no payment or email required.tc pixel
Mesa Laboratories (MLAB) Expected to Release Earnings on Monday
Mesa Laboratories declares $0.16 dividend
MESA LABS DECLARES QUARTERLY DIVIDEND
See More Headlines

MLAB Stock Analysis - Frequently Asked Questions

Mesa Laboratories' stock was trading at $78.50 at the beginning of the year. Since then, MLAB shares have increased by 44.2% and is now trading at $113.20.

Mesa Laboratories, Inc. (NASDAQ:MLAB) posted its quarterly earnings data on Monday, August, 10th. The medical instruments supplier reported $2.68 earnings per share (EPS) for the quarter. The medical instruments supplier earned $60.14 million during the quarter. Mesa Laboratories had a trailing twelve-month return on equity of 22.87% and a net margin of 1.92%.
Read the conference call transcript
.

Mesa Laboratories' top institutional shareholders include Ranger Investment Management L.P. (3.11%), Diamond Hill Capital Management LLC Investment Advisor (2.78%), Wasatch Advisors LP (2.10%) and Bank of New York Mellon Corp (0.81%). Insiders that own company stock include John Bradley Schmieder, Gary M Owens, John Sakys, Shiraz Shabanali Ladiwala, Brian David Archbold, R Tony Tripeny, Mark Christopher Capone and Lyndsey Elizabeth Crennen.
View institutional ownership trends
.

Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mesa Laboratories investors own include American Water Works (AWK), Waste Connections (WCN), AUO (AUOTY), DiamondRock Hospitality (DRH), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Record date for 6/15 Dividend
5/29/2026
Ex-Dividend for 6/15 Dividend
5/29/2026
Dividend Payable
6/15/2026
Last Earnings
8/10/2026
Today
8/14/2026
Record date for 9/15 Dividend
8/31/2026
Ex-Dividend for 9/15 Dividend
8/31/2026
Dividend Payable
9/15/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:MLAB
CIK
724004
Employees
680
Year Founded
1982

Price Target and Rating

High Price Target
$110.00
Low Price Target
$110.00
Potential Upside/Downside
+0.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.84
Trailing P/E Ratio
130.14
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$6.71 million
Net Margins
1.92%
Pretax Margin
4.82%
Return on Equity
22.87%
Return on Assets
9.75%

Debt

Debt-to-Equity Ratio
0.78
Current Ratio
1.72
Quick Ratio
1.29

Sales & Book Value

Annual Sales
$249.73 million
Price / Sales
2.45
Cash Flow
$11.41 per share
Price / Cash Flow
9.58
Book Value
$33.71 per share
Price / Book
3.24

Miscellaneous

Outstanding Shares
5,596,000
Free Float
5,439,000
Market Cap
$611.73 million
Optionable
Not Optionable
Beta
0.92

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:MLAB) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners